Quality-of-Life and Oncological Outcomes in Male Breast Cancer: Insights from an Extensive 20-Year Experience
Massimo Ferrucci(Istituto Oncologico Veneto), Alberto Marchet(Istituto Oncologico Veneto), Silvia Michieletto(Istituto Oncologico Veneto), Francesco Milardi(University of Padua), Mariacristina Toffanin(Istituto Oncologico Veneto), Paola Del Bianco(Istituto Oncologico Veneto), Tania Saibene(Istituti di Ricovero e Cura a Carattere Scientifico), Daniele Passeri(University of Padua), Maria Pozzerle(Don Carlo Gnocchi Foundation), Matteo Cagol(Istituto Oncologico Veneto)
Cited by 5
Related Papers
A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer
|Annals of Surgery|2008|313
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
|Annals of Surgical Oncology|2022|162
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
|npj Breast Cancer|2021|100
Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?
|Journal of Gastrointestinal Surgery|2013|95